6230 尼得科超眾本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | 105.44 | 155.00 |
| 2026/04 | 108.16 | 159.00 |
| 2026/03 | 94.22 | 138.50 |
| 2026/02 | 106.80 | 157.00 |
| 2026/01 | 82.31 | 121.00 |
| 2025/12 | 78.23 | 115.00 |
| 2025/11 | 79.25 | 116.50 |
| 2025/10 | 92.86 | 136.50 |
| 2025/09 | 100.34 | 147.50 |
| 2025/08 | 99.32 | 146.00 |
| 2025/07 | 691.67 | 124.50 |
| 2025/06 | 700.00 | 126.00 |
| 2025/05 | 713.89 | 128.50 |
| 2025/04 | 89.19 | 132.00 |
| 2025/03 | 103.72 | 153.50 |
| 2025/02 | 125.68 | 186.00 |
| 2025/01 | 153.48 | 176.50 |
| 2024/12 | 170.00 | 195.50 |
| 2024/11 | 169.57 | 195.00 |
| 2024/10 | 57.74 | 212.50 |
| 2024/09 | 61.14 | 225.00 |
| 2024/08 | 68.75 | 253.00 |
| 2024/07 | 39.39 | 252.50 |
| 2024/06 | 51.64 | 331.00 |
| 2024/05 | 53.12 | 340.50 |
| 2024/04 | 46.23 | 324.50 |
| 2024/03 | 27.21 | 191.00 |
| 2024/02 | 20.37 | 143.00 |
| 2024/01 | 14.29 | 131.50 |
| 2023/12 | 16.30 | 150.00 |
| 2023/11 | 14.02 | 129.00 |
| 2023/10 | 12.27 | 119.50 |
| 2023/09 | 15.09 | 147.00 |
| 2023/08 | 15.76 | 153.50 |
| 2023/07 | 19.98 | 171.00 |
| 2023/06 | 18.63 | 159.50 |
| 2023/05 | 20.79 | 178.00 |
| 2023/04 | 22.68 | 161.00 |
| 2023/03 | 21.06 | 149.50 |
| 2023/02 | 16.62 | 118.00 |
| 2023/01 | 25.22 | 116.50 |
| 2022/12 | 25.11 | 116.00 |
| 2022/11 | 28.14 | 130.00 |
| 2022/10 | 33.61 | 100.50 |
| 2022/09 | 32.31 | 96.60 |
| 2022/08 | 37.63 | 112.50 |
| 2022/07 | 57.73 | 104.50 |
| 2022/06 | 57.46 | 104.00 |
| 2022/05 | 63.54 | 115.00 |
| 2022/04 | 29.38 | 119.00 |
| 2022/03 | 30.86 | 125.00 |
| 2022/02 | 38.15 | 154.50 |
| 2022/01 | 25.91 | 163.00 |
| 2021/12 | 26.39 | 166.00 |
| 2021/11 | 26.31 | 165.50 |
| 2021/10 | 20.98 | 167.00 |
| 2021/09 | 21.29 | 169.50 |
| 2021/08 | 22.49 | 179.00 |
| 2021/07 | 20.67 | 205.50 |
| 2021/06 | 20.98 | 208.50 |
| 2021/05 | 20.32 | 202.00 |
| 2021/04 | 24.01 | 217.50 |
| 2021/03 | 23.57 | 213.50 |
| 2021/02 | 23.90 | 216.50 |
| 2021/01 | - | 212.50 |